RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
1.085
-0.005 (-0.46%)
At close: May 1, 2026, 4:00 PM EDT
1.080
-0.005 (-0.46%)
After-hours: May 1, 2026, 7:40 PM EDT

RedHill Biopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3.974.625.5719.9729.47
Short-Term Investments
---0.028.53
Cash & Short-Term Investments
3.974.625.5719.9838
Cash Growth
-13.99%-17.09%-72.13%-47.42%27.56%
Accounts Receivable
0.082.542.5934.5231.68
Inventory
-3.654.3911.0114.81
Other Current Assets
2.481.13.5920.394.66
Total Current Assets
6.5311.9116.1485.989.15
Net Property, Plant & Equipment
1.110.441.187.194.22
Other Intangible Assets
5.295.555.5865.6371.64
Long-Term Investments
12.05----
Other Long-Term Assets
0.370.150.150.1516.17
Total Assets
25.3518.0423.05158.87181.19
Accounts Payable
0.731.173.284.2311.66
Accrued Expenses
12.029.994.5917.9520.9
Current Portion of Long-Term Debt
---115.22-
Current Portion of Leases
0.170.350.721.031.62
Other Current Liabilities
6.310.7111.459.0347.29
Total Current Liabilities
19.2222.2219.98197.4581.47
Long-Term Debt
----83.62
Long-Term Leases
0.900.466.442.57
Other Long-Term Liabilities
0.960.50.543.374.65
Total Long-Term Liabilities
1.860.519.8290.84
Total Liabilities
21.0822.7320.98207.27172.31
Common Stock
147.6435.0421.442.841.5
Additional Paid-in Capital
270.38375.08388.36382.63375.25
Retained Earnings
-413.76-414.8-407.74-433.86-367.87
Shareholders' Equity
4.27-4.682.07-48.48.88
Total Liabilities & Equity
25.3518.0423.05158.87181.19
Total Debt
1.070.361.17122.6987.81
Net Cash (Debt)
2.94.264.4-102.71-49.81
Net Cash Growth
-31.92%-3.07%---
Net Cash Per Share
0.923.4616.96-1666.53-1070.51
Book Value
4.27-4.682.07-48.48.88
Book Value Per Share
1.35-3.807.98-785.33190.75
Tangible Book Value
-1.02-10.23-3.51-114.03-62.77
Tangible Book Value Per Share
-0.32-8.30-13.54-1850.17-1349.08
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q